Synlogic, Inc. ( SYBX) - Key Metrics
SYBX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q3 | ? | -$0.01 | -$0.05 | -$0.05 |
| 2024Q2 | ? | $0.16 | -$1.23 | -$1.20 |
| 2024Q1 | $0 | -$2.60 | -$1.27 | -$1.30 |
| 2023Q4 | $0.32 | -$1.71 | -$0.65 | -$0.65 |
| 2023Q3 | $0.08 | -$2.57 | -$2.76 | -$2.76 |
SYBX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q3 | ? | -38.92 |
| 2024Q2 | ? | 2.26 |
| 2024Q1 | ? | -0.17 |
| 2023Q4 | ? | -0.56 |
| 2023Q3 | ? | -0.27 |
SYBX
Price: $1.20
52 week price:
Earnings Per Share: -0.26 USD
P/E Ratio: -2.31
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 107155
Ebitda: -10.6 millionMarket Capitalization: 13.7 million